Clinical Significance of Tissue Levels of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Gastric Cancer

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2007 Mar 14

PMID 17351800

Citations 18

Authors

Ki-Nam Shim

Sung-Ae Jung

Yang-Hee Joo

Kwon Yoo

Affiliations

Soon will be listed here.

Abstract

Background: Matrix metalloproteinases (MMPs) are one of the major classes of proteolytic enzymes involved in tumor invasion and metastasis, being inhibited by naturally occurring tissue inhibitors of metalloproteinases (TIMPs). In this study, we examined the expression of MMP-2, MMP-9, membrane-type 1 (MT1)-MMP, TIMP-1, and TIMP-2 in biopsy tissues of gastric cancer, and the correlation between their expression and clinicopathological parameters.

Methods: Biopsy specimens from 66 patients with gastric carcinoma were available for this study. To determine the expression of MMP-2, MMP-9, MT1-MMP, TIMP-1, and TIMP-2, semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out on tumor and normal tissues, respectively, sampled during diagnostic gastroscopic examination. Immunohistochemical staining of representative samples using monoclonal antibody directed against MT1-MMP was done, and the clinicopathological variables were reviewed retrospectively.

Results: The expression level of MMPs and TIMPs was evaluated using the tumor : normal (T/N) ratios of MMPs and TIMPs. The T/N ratio of MT1-MMP mRNA showed a significant correlation with lymph node metastasis and tumor stage (P < 0.05). The other RT-PCR data of MMP-2, MMP-9, TIMP-1, and TIMP-2 did not show any significant correlation with clinicopathological parameters. Immunohistochemistry for MT1-MMP showed a positive immunoreaction in gastric adenocarcinoma and negative staining in normal mucosa.

Conclusions: The correlation between the increased expression of MT1-MMP and clinicopathological variables reflects a role in predicting the aggressive behavior of gastric cancer. Because an RT-PCR assay can be performed on biopsy specimens obtained before surgery, an evaluation of MT1-MMP expression in biopsy specimens by RT-PCR may provide useful preoperative information on tumor aggressiveness.

Citing Articles

Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.

Romanowicz A, Lukaszewicz-Zajac M, Mroczko B Int J Mol Sci. 2024; 25(8).

PMID: 38673838 PMC: 11050399. DOI: 10.3390/ijms25084253.

The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.

Pawluczuk E, Lukaszewicz-Zajac M, Mroczko B Int J Mol Sci. 2023; 24(10).

PMID: 37240178 PMC: 10218496. DOI: 10.3390/ijms24108833.

Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation.

Su S, Shi Y, Chu Y, Jiang M, Wu N, Xu B Cell Mol Life Sci. 2022; 79(2):133.

PMID: 35165763 PMC: 11073224. DOI: 10.1007/s00018-022-04143-2.

Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis.

Andreuzzi E, Capuano A, Poletto E, Pivetta E, Fejza A, Favero A Int J Mol Sci. 2020; 21(10).

PMID: 32456248 PMC: 7279269. DOI: 10.3390/ijms21103686.

P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.

Song H, Liu L, Song Z, Ren Y, Li C, Huo J Technol Cancer Res Treat. 2018; 17:1533033818796485.

PMID: 30198421 PMC: 6131293. DOI: 10.1177/1533033818796485.

References

Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H . Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J Biochem. 1998; 124(2):462-70. DOI: 10.1093/oxfordjournals.jbchem.a022136. View

Bando E, Yonemura Y, Endou Y, Sasaki T, Taniguchi K, Fujita H . Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep. 1998; 5(6):1483-8. DOI: 10.3892/or.5.6.1483. View

Curran S, Murray G . Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000; 36(13 Spec No):1621-30. DOI: 10.1016/s0959-8049(00)00156-8. View

Richards C, Agro A . Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine. 1994; 6(1):40-7. DOI: 10.1016/1043-4666(94)90006-x. View

Alexander C, Werb Z . Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol. 1992; 118(3):727-39. PMC: 2289547. DOI: 10.1083/jcb.118.3.727. View

Avalos B, Kaufman S, Tomonaga M, Williams R, Golde D, Gasson J . K562 cells produce and respond to human erythroid-potentiating activity. Blood. 1988; 71(6):1720-5. View

Maatta M, Soini Y, Liakka A, Autio-Harmainen H . Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res. 2000; 6(7):2726-34. View

Wang Z, Juttermann R, Soloway P . TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem. 2000; 275(34):26411-5. PMC: 2683068. DOI: 10.1074/jbc.M001270200. View

Pyke C, Ralfkiaer E, Tryggvason K, Dano K . Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 1993; 142(2):359-65. PMC: 1886712. View

10.

Sier C, Kubben F, Ganesh S, Heerding M, Griffioen G, Hanemaaijer R . Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer. 1996; 74(3):413-7. PMC: 2074643. DOI: 10.1038/bjc.1996.374. View

11.

Yamagata S, Tanaka R, Ito Y, Shimizu S . Gelatinases of murine metastatic tumor cells. Biochem Biophys Res Commun. 1989; 158(1):228-34. DOI: 10.1016/s0006-291x(89)80202-5. View

12.

Seiki M, Yana I . Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci. 2003; 94(7):569-74. PMC: 11160244. DOI: 10.1111/j.1349-7006.2003.tb01484.x. View

13.

Kohn E, Liotta L . Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 1995; 55(9):1856-62. View

14.

Chen W . Membrane proteases: roles in tissue remodeling and tumour invasion. Curr Opin Cell Biol. 1992; 4(5):802-9. DOI: 10.1016/0955-0674(92)90103-j. View

15.

Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J . Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene. 1992; 7(1):77-83. View

16.

Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N . Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 2001; 20(17):4782-93. PMC: 125610. DOI: 10.1093/emboj/20.17.4782. View

17.

Tryggvason K, Hoyhtya M, Pyke C . Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993; 24(3):209-18. DOI: 10.1007/BF01833261. View

18.

Nomura H, Sato H, Seiki M, Mai M, Okada Y . Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995; 55(15):3263-6. View

19.

Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E . A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994; 370(6484):61-5. DOI: 10.1038/370061a0. View

20.

Passlick B, Sienel W, Wockel W, Thetter O, Mutschler W, Pantel K . Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res. 2000; 6(10):3944-8. View